Emisphere Announces $20 Million Debt Financing to Launch Oral Eligen(R) B12

Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that it has reached agreement with MHR Fund Management LLC, and certain of its affiliated funds ("MHR"), to finance the upcoming launch of the Company's first commercial prescription product, oral Eligen B12 in the United States through a new loan facility, and to amend the terms of the Company's existing obligations under various promissory notes previously issued to MHR to extend the maturity dates of such promissory notes.
http://bit.ly/1uWyK6x